The strong market consensus favoring no new pandemic in 2026 stems primarily from ongoing global surveillance data showing no novel pathogens with sustained human-to-human transmission or pandemic potential as of late September. Authoritative monitoring by the WHO and CDC indicates stable incidence rates for known respiratory viruses, with no clusters exceeding baseline thresholds or exhibiting unusual virulence. Historical patterns and current epidemiological indicators, including low zoonotic spillover signals from avian influenza and other strains, reinforce this assessment. While model uncertainty persists, an unexpected mutation enabling efficient transmission or a sudden undetected outbreak could still shift outcomes before year-end.